The LouseBuster Returns: Head Lice Shrivel in New Study

Key points
- Four years after the LouseBuster prototype made headlines when research showed the chemical-free, warm-air device wiped out head lice on children, a new study reveals that a revamped, government-cleared model is highly effective.
- The most widely used delousing products are shampoos and other chemical treatments toxic to lice.
- The new LouseBuster study compared the number of live and dead lice and nits before and after treatment on the 56 study participants.
- The new study of 56 louse-infested children and adults – soon to be published in the January 2011 issue of the Journal of Medical Entomology – found 94.8 percent of lice and their eggs, known as nits, were dead after treatment with the LouseBuster.
Four years after the LouseBuster prototype made headlines when research showed the chemical-free, warm-air device wiped out head lice on children, a new study reveals that a revamped, government-cleared model is highly effective.
“For a louse, it’s like sticking your head out a window at 100 miles an hour; they’re going to get dried out,” says University of Utah biology Professor Dale Clayton, senior author of the study and a founder of Larada Sciences, a university spinoff company that sells or leases the LouseBuster to schools, camps, medical clinics and delousing businesses.
The new study of 56 louse-infested children and adults – soon to be published in the January 2011 issue of the Journal of Medical Entomology – found 94.8 percent of lice and their eggs, known as nits, were dead after treatment with the LouseBuster.
The original LouseBuster prototype proved effective in a study published in November 2006 in the journal Pediatrics. But it was noisy, wouldn’t plug into home electrical outlets and got tangled in curly hair. It looked like a cumbersome canister vacuum with a hose on it, and blew warm air through a comb-like applicator.
After the first study, thousands of people with louse-infested children contacted Clayton and the University of Utah seeking the device, even though it was only a research prototype and was meant for eventual use by school nurses and other delousing professionals, not private individuals. It took three more years for the revamped LouseBuster to hit the market after gaining U.S. Food and Drug Administration clearance as a medical device. It was patented in September 2010.
“We’ve moved from clinical trials to having the machine available so infested people can get treated by this device. It’s not a prototype anymore,” says the study’s first author, Sarah Bush, an assistant professor of biology at the University of Utah.
The new LouseBuster sports improvements over the prototype: less noise, the ability to plug into a standard electrical outlet and an applicator that doesn't get tangled in hair. The applicator delivers air through 28 cone-shaped tips held against the scalp.
Larada Sciences sells the LouseBuster for $2,000 to $2,500 to nonprofit organizations such as schools and medical clinics. The company also has various sale or lease arrangements with trained and certified LouseBuster operators who provide treatments in salons or clients’ homes for $125 to $275 per person. Such small delousing businesses have been springing up recently as head lice have become more prevalent.
Bush and Clayton ran the study with Alex Rock, Sherri Jones and Jael Malenke, research technicians from Larada Sciences in Salt Lake City. The study was funded by the National Science Foundation, Utah Centers of Excellence program and Larada Sciences. Clayton and some other authors have a financial interest in the company.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Children's Health →
NewsBasic research led to first FDA-approved immunotherapy for pediatric cancer
Building upon more than two decades of basic research conducted at Children's Hospital Los Angeles, Araz Marachelian, MD, of CHLA, and her colleagues at pediatric academic centers across the U. S., have shown that an…
29 January 2016
NewsNew study holds hope for improving outcomes for children exposed to methamphetamine
Despite continuing reports that methamphetamine abuse during pregnancy can lead to behavioral and emotional problems in children, pregnant women continue to abuse the illicit drug. Nearly one-fourth of pregnant women…
22 January 2016
NewsMathematics for child health
Many people in Russia know about the Dima Rogachev Centre - particularly those who have faced the challenge of child cancer. The centre is Europe's largest pediatric cancer care facility and is named after a boy with…



